Alexander V. Murray

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity

Louis J. Aronne, Naveed Sattar, Deborah B. Horn et al. · JAMA · 2023 · 709 citations · Full text

Agriculture, Pharmacotherapy, Clinical Pharmacology +16

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi et al. · Diabetes Care · 2019 · 468 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial

Robert R. Henry, Alexander V. Murray, Marisol Herrera Marmolejo et al. · International Journal of Clinical Practice · 2012 · 314 citations

Medicine, Pharmacology, Pharmacotherapy +17